Back to Search
MARCUS BOSENBERG, M.D., PH.D.
M.D., PH.D.
Dermatopathology (Pathology) Physician
NPI: 1679595094IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatopathology (Pathology) PhysicianPrimary
Pathology — Dermatopathology
Code: 207ZD0900X
042-0010348(VT)
CMS Specialties
PrimaryUNDEFINED PHYSICIAN TYPE (SPECIFY)
Additional
PATHOLOGY
Education
JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Class of 1994
Research & Publications (20)
Characterization of melanocyte-specific inducible Cre recombinase transgenic mice.
PMID 16676322·Genesis·2006
7-preclinical
Autoimmune acrosyringitis with ductal cysts: reclassification of case of eruptive syringoma.
PMID 19522848·J Cutan Pathol·2009
5-case
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.
PMID 19282848·Nat Genet·2009
7-preclinical
Nifurtimox induces apoptosis of neuroblastoma cells in vitro and in vivo.
PMID 19262245·J Pediatr Hematol Oncol·2009
7-preclinical
Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression.
PMID 18632627·Cancer Res·2008
7-preclinical
A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin.
PMID 18353136·Pigment Cell Melanoma Res·2008
7-preclinical
LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.
PMID 18172296·Cancer Res·2008
7-preclinical
Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.
PMID 17575131·Cancer Res·2007
7-preclinical
Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
PMID 17360455·Proc Natl Acad Sci U S A·2007
7-preclinical
Epigenetic silencing of novel tumor suppressors in malignant melanoma.
PMID 17145863·Cancer Res·2006
7-preclinical
Precancer in mice: animal models used to understand, prevent, and treat human precancers.
PMID 17074738·Toxicol Pathol·2006
7-preclinical
Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo.
PMID 16977322·EMBO J·2006
7-preclinical
Amplification of CDK4 and MDM2 in malignant melanoma.
PMID 16419059·Genes Chromosomes Cancer·2006
8-other
Role of epidermal growth factor receptor signaling in RAS-driven melanoma.
PMID 15870287·Mol Cell Biol·2005
7-preclinical
Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
PMID 15488760·Cancer Cell·2004
7-preclinical
Deregulated Akt3 activity promotes development of malignant melanoma.
PMID 15466193·Cancer Res·2004
7-preclinical
Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases.
PMID 15371941·Am J Surg Pathol·2004
8-other
Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
PMID 12902988·Oncogene·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 111 COLCHESTER AVE
BURLINGTON, VT 05401 - Phone
- (802) 847-9447
Quick Facts
- NPI
- 1679595094
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile